Boehringer Ingelheim - Quality Improvement Education Grants

Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) is proud to support Quality Improvement Education (QIE) grants examining novel educational methodologies and approaches that address clinical performance measures or quality indicators aligned to National Quality Priorities.

Specific QIE initiatives will focus on demonstrating improvement of patient care within health care organizations and will disseminate the impact of specific QIE initiatives via publications or real-world data reporting.

Types of QIE Initiatives

QIE initiatives include interventions designed independent of BIPI’s input or involvement and may or may not include education that is certified for healthcare professionals.  For those initiatives that do provide a form of certified education (CE), BIPI cannot provide any resources or expertise into the development or execution of the educational interventions to ensure that the Independent Medical Education (IME) component remains free from BIPI influence. 

BIPI also provides support for collaborative QIE opportunities where BIPI may partner with an outside professional or medical association or society.  Involvement may include dissemination of a BIPI Request for Proposal to their members and/or assembling a final external review committee for funding decisions.

BIPI currently accepts QIE Applications in the following Areas of Interest

  • Cardiovascular
  • Oncology
  • Diabetes
  • Respiratory
Agency Name: 
Boehringer Ingelheim
Contact Name: 
Gillian Laird, grant facilitator U of Lethbridge. Email: | (403) 329-2101
Grant Location: 
Grant Type: 
Grant Area: 
Natural Science
Grant Eligibility: